Edward Hu, M.B.A.

Board Member

Mr. Edward Hu is currently chief financial officer and chief investment officer at WuXi AppTec. He is the co-founder and managing partner at WuXi Healthcare Ventures, a cross board healthcare focused venture fund. Mr. Hu manages WuXi AppTec’s finance, investments, mergers and acquisitions, joint ventures, and new business and capability building. In addition, Mr. Hu oversees WuXi Healthcare Ventures’ investment activities and portfolio management. Mr. Hu previously served as WuXi’s chief operating officer and chief financial officer for five years until April 2014. Prior to joining WuXi in August 2007, he was a senior vice president and chief operating officer at Tanox, a biopharmaceutical company acquired by Genentech. He also held positions at Merck & Co., Inc. as a senior financial analyst and later in business and financial planning at Biogen, Inc. Mr. Hu completed his Ph.D. work, all but dissertation, in biophysics and biochemistry at Carnegie Mellon University, where he also received his M.B.A.